4.6 Article

The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK plus anaplastic large cell lymphoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise?

Eitan Shaulian

CELLULAR SIGNALLING (2010)

Article Medicine, General & Internal

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.

Anas Younes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemistry & Molecular Biology

The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination

Roberto Chiarle et al.

NATURE MEDICINE (2008)

Article Pathology

c-Jun expression and activation are restricted to CD30(+) lymphoproliferative disorders

Elias Drakos et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)

Article Biochemistry & Molecular Biology

Cell cycle promoting activity of JunB through cyclin A activation

S Andrecht et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Genetics & Heredity

JunB can substitute for Jun in mouse development and cell proliferation

E Passegué et al.

NATURE GENETICS (2002)

Article Biochemistry & Molecular Biology

JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression

E Passegué et al.

EMBO JOURNAL (2000)